Fischer Medical Ventures Ltd - 524743 - Corporate Action-Board approves Dividend
Fischer Medical Ventures board recommends a final dividend of ₹0.05 per equity share for FY26. This 5% dividend on ₹1 face value will be paid within 30 days of shareholder approval at the AGM.
May 30 2026 03:05:26
Fischer Medical Ventures Ltd - 524743 - Board Meeting Outcome for Oucome Of BM
Fischer Medical Ventures board approved audited financial results for Q4 and full FY26. Cons. Q4 FY26 revenue was ₹97.73 cr with a net loss of ₹7.11 cr. The company also recommended a final dividend of ₹0.05/share for FY26 and appointed S. Ramanand Aiyer & Co. as Internal Auditors for FY2026-27.
May 30 2026 01:54:33
Fischer Medical Ventures Ltd - 524743 - Board Meeting Intimation for Audit Financial Results Q4 And FY Ending 31St March 2026
Fischer Medical Ventures' Board of Directors will hold a meeting on May 29, 2026. The agenda includes considering the Q4 FY26 and FY26 financial results and the recommendation of a dividend.
May 25 2026 12:44:47
Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Fischer Medical Ventures' Monitoring Agency Report for Q4 FY26 confirms that funds from the preferential issue, totaling Rs.280.93 crore, were utilized as per the stated objectives with nil deviation. This includes Rs.10.53 crore used for general corporate purposes, specifically loan repayment to TMVIPL.
May 15 2026 18:41:24
Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fischer Medical Ventures' subsidiary, Time Medical International Ventures (India) Pvt. Ltd., has partnered with the WFNS Innovation & Technology Committee. This collaboration marks the first time WFNS has formally partnered with an industry player, focusing on advancing neurosurgical care through advanced medical imaging and technology.
May 14 2026 12:50:16
Read More